• Satoshi Sawauchi, Keisuke Taya, Shigeyuki Murakami, Takuya Ishi, Toshihiro Ohtsuka, Naoki Kato, Shougo Kaku, Toshihide Tanaka, Satoru Morooka, Kenji Yuhki, Mitsuyoshi Urashima, and Toshiaki Abe.
• Department of Neurosurgery, Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan. sawauchi@jb4.so-net.ne.jp
• No Shinkei Geka. 2005 Nov 1;33(11):1073-80.

ObjectiveThe aim of this study was to investigate S-100B protein and NSE as a serum marker of brain cell damage after traumatic brain injury.Material And MethodsForty-one patients with traumatic brain injury were included in this prospective study. Venous blood samples for S-100B protein and NSE were taken after admission and on the next day. Serum levels of S-100 protein and NSE were compared with Glasgow Coma Scale score, computed tomographic findings and outcome after 3 months.ResultsSerum S-100B protein and NSE were significantly correlated with Glasgow Coma Scale score and outcome after 3 months. The significant correlation was found between the initial S-100B and NSE (P < 0.001). In patients without parenchymal injuries on computed tomographic scan such as epidural hematoma and concussion, the elevation of S-100B protein and NSE was observed. The initial values of S-100B and NSE in acute subdural hematomas with unfavorable outcome were significantly higher than in those with favorable outcome. Secondary increase of serum markers was associated with the presence of secondary insult such as hypoxia or hypotension, and was found to have an unfavorable outcome.ConclusionsSerum concentration and kinetics of S-100B protein and NSE provide the clinical assessment of the primary brain damage and have a predictive value for outcome after traumatic brain injury.

18 keywords...

hide…